Literature DB >> 31705282

[Surgical approach to benign bile duct alterations].

A Alvanos1, S Rademacher1, A Hoffmeister2, D Seehofer3.   

Abstract

BACKGROUND: Benign biliary diseases comprise entities, which present with very similar pathognomonic symptoms despite fundamental etiological differences. Obstructions of intrahepatic and extrahepatic bile ducts due to stones, tumors or parasites as well as stenoses and cystic alterations belong to the group of benign biliary diseases.
OBJECTIVE: This article provides a systematic overview of the indications and differential treatment of benign biliary diseases with special emphasis on the surgical treatment.
MATERIAL AND METHODS: The presented recommendations are in accordance with national and international guidelines, current scientific papers and expert opinions.
RESULTS: Essentially the surgical options for benign biliary diseases consist of revision, reconstruction through bilioenteric anastomosis, resection and complete organ replacement in the sense of liver transplantation. The location of the affected segment of the biliary tree, the symptoms, the progress of the disease and suspected malignancy essentially determine the level of escalation in the described treatment level scheme.
CONCLUSION: The treatment of benign biliary diseases is complex and requires achievement of unimpaired, unobstructed bile drainage. It serves the purpose of resolving cholestasis and thereby avoiding recurrent cholangitis and long-term complications, such as biliary cirrhosis and malignant transformation; however, in some cases of premalignant lesions of the bile ducts the strategy resembles cancer surgery, including resection of the affected tissue.

Entities:  

Keywords:  Biliary tumors; Caroli disease; Choledocholithiasis; Hepatolithiasis; Parasitosis

Year:  2020        PMID: 31705282     DOI: 10.1007/s00104-019-01061-1

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  31 in total

Review 1.  Biliary cysts.

Authors:  P D Flanigan
Journal:  Ann Surg       Date:  1975-11       Impact factor: 12.969

2.  Mucinous cystic neoplasms of the liver: a clinicopathological study and comparison with intraductal papillary neoplasms of the bile duct.

Authors:  Yoh Zen; Federica Pedica; Venkata R Patcha; Paola Capelli; Giuseppe Zamboni; Andrea Casaril; Alberto Quaglia; Yasuni Nakanuma; Nigel Heaton; Bernard Portmann
Journal:  Mod Pathol       Date:  2011-04-22       Impact factor: 7.842

Review 3.  Intraductal Papillary Neoplasm of the Bile Duct: Clinical, Imaging, and Pathologic Features.

Authors:  Hyo Jung Park; So Yeon Kim; Hyoung Jung Kim; Seung Soo Lee; Gil Sun Hong; Jae Ho Byun; Seung-Mo Hong; Moon-Gyu Lee
Journal:  AJR Am J Roentgenol       Date:  2018-04-09       Impact factor: 3.959

Review 4.  Genetic determinants of cholangiopathies: Molecular and systems genetics.

Authors:  Matthias C Reichert; Rabea A Hall; Marcin Krawczyk; Frank Lammert
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-07-27       Impact factor: 5.187

Review 5.  [Intraductal papillary neoplasms of the bile duct (IPNB). Diagnostic criteria, carcinogenesis and differential diagnostics].

Authors:  A M Schlitter; G Klöppel; I Esposito
Journal:  Pathologe       Date:  2013-11       Impact factor: 1.011

6.  Endoscopic biliary stenting: indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline - Updated October 2017.

Authors:  Jean-Marc Dumonceau; Andrea Tringali; Ioannis S Papanikolaou; Daniel Blero; Benedetto Mangiavillano; Arthur Schmidt; Geoffroy Vanbiervliet; Guido Costamagna; Jacques Devière; Jesús García-Cano; Tibor Gyökeres; Cesare Hassan; Frédéric Prat; Peter D Siersema; Jeanin E van Hooft
Journal:  Endoscopy       Date:  2018-08-07       Impact factor: 10.093

7.  Preoperative Cholangitis and Future Liver Remnant Volume Determine the Risk of Liver Failure in Patients Undergoing Resection for Hilar Cholangiocarcinoma.

Authors:  Dario Ribero; Giuseppe Zimmitti; Thomas A Aloia; Junichi Shindoh; Forchino Fabio; Marco Amisano; Guillaume Passot; Alessandro Ferrero; Jean-Nicolas Vauthey
Journal:  J Am Coll Surg       Date:  2016-02-13       Impact factor: 6.113

8.  [Updated S3-Guideline for Prophylaxis, Diagnosis and Treatment of Gallstones. German Society for Digestive and Metabolic Diseases (DGVS) and German Society for Surgery of the Alimentary Tract (DGAV) - AWMF Registry 021/008].

Authors:  Carsten Gutt; Christian Jenssen; Ana-Paula Barreiros; Thorsten O Götze; Caroline S Stokes; Petra Lynen Jansen; Michael Neubrand; Frank Lammert
Journal:  Z Gastroenterol       Date:  2018-08-13       Impact factor: 2.000

Review 9.  [Differential diagnoses of biliary tract diseases : Computed tomography and magnetic resonance imaging].

Authors:  K Lampichler; M Scharitzer
Journal:  Radiologe       Date:  2019-04       Impact factor: 0.635

10.  Clinical practice guidelines for IgG4-related sclerosing cholangitis.

Authors:  Terumi Kamisawa; Takahiro Nakazawa; Susumu Tazuma; Yoh Zen; Atsushi Tanaka; Hirotaka Ohara; Takashi Muraki; Kazuo Inui; Dai Inoue; Takayoshi Nishino; Itaru Naitoh; Takao Itoi; Kenji Notohara; Atsushi Kanno; Kensuke Kubota; Kenji Hirano; Hiroyuki Isayama; Kyoko Shimizu; Toshio Tsuyuguchi; Tooru Shimosegawa; Shigeyuki Kawa; Tsutomu Chiba; Kazuichi Okazaki; Hajime Takikawa; Wataru Kimura; Michiaki Unno; Masahiro Yoshida
Journal:  J Hepatobiliary Pancreat Sci       Date:  2019-01-18       Impact factor: 7.027

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.